OR Manager Conference (formerly Managing Today’s OR Suite), brings together more than 1, 400 managers and directors involved in leading the surgical suite for 3 days of continuing education and networking opportunities. The conference builds on the content developed in each issue of OR Manager, providing you with a live learning experience. Earn CEs, AEUs, and explore new technologies with solution providers.
OR Manager Conference provides you with plenty of opportunities to earn contact hours throughout the three days you will spend in Orlando!Learn More
Editor’s Note Surgeon and Harvard Medical School professor Atul Gawande, MD, has been named CEO of the Boston-based Amazon, JP Morgan Chase, and Berkshire Hathaway healthcare venture, the June 20 Modern Healthcare reports. The companies, which are focused on lowering the cost of care primarily for their nearly 1.2 million employees, will initially focus on […]
The post Atul Gawande named CEO of new Amazon led healthcare company appeared first on OR Manager.
Editor’s Note In patients with traumatic out-of-hospital cardiac arrest (OHCA) after traffic collisions, advanced life support (ALS) performed by physicians was associated with increased chance of 1-month survival compared with ALS or basic life support (BLS) performed by emergency medical services (EMS) personnel, this Japanese study finds. Of 4,328 patients analyzed, 96 (2.2%) survived 1 […]
The post ALS by physicians linked to increased survival appeared first on OR Manager.
Editor’s Note In a study on the effectiveness of reprocessing flexible bronchoscopes presented June 14 by Ofstead and Associates at the Association for Professionals in Infection Control’s annual conference in Minneapolis, the majority of bronchoscopes were found to be contaminated and damaged even when cleaned and high-level disinfected according to reprocessing guidelines, the June 19 […]
The post Effectiveness of reprocessing reusable flexible bronchoscopes appeared first on OR Manager.
Editor’s Note In a June 19 letter to healthcare providers, the Food & Drug Administration (FDA) says it continues to evaluate information from several sources, including manufacturers, on the risks associated with Type III endoleaks with various endovascular graft systems used for treatment of abdominal aortic aneurysms (AAAs) and aorto-iliac aneurysms. Based on new information, […]
The post FDA letter updates risks of Type III endoleaks with aortic endovascular graft systems appeared first on OR Manager.